ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,727.07
      0.15%
      US Tech 100
      19,356.80
      0.18%
      Dow Jones
      42,130.74
      0.01%
      Brent Oil
      74.61
      1.19%
      Bitcoin
      63,798.09
      0.74%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Ionis Pharmaceuticals Inc (IONS)

      7. Ionis Pharmaceuticals Inc (IONS) News

      IONS

      Ionis Pharmaceuticals (IONS)

      Ionis Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IONS
      DateTimeSourceHeadlineSymbolCompany
      12:50PMiHub NewswireFeaturedCannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference
      12:45PMiHub NewswireFeaturedIntegrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC.
      09/10/20245:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/09/20249:10PMPR Newswire (US)Ionis announces pricing of $500.3 million public offeringNASDAQ:IONSIonis Pharmaceuticals Inc
      09/09/20244:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IONSIonis Pharmaceuticals Inc
      09/09/20244:23PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/09/20244:20PMPR Newswire (US)Ionis announces proposed public offering of common stockNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:51PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:40PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:33PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:33PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:29PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:27PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:25PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:24PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:23PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:21PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:20PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:19PMEdgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:13PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:11PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:06PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20249:02PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20248:52PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20248:51PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
      09/04/20248:42PMEdgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:IONSIonis Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IONS